Article | February 1, 2021
The Market For 3D Printed Bioresorbable CMF Plates And Other Complex Devices Is Being Redefined By New GMP-Grade Filament Material
By Balaji Prabhu, Director Strategic Marketing, Medical Device Solutions, Evonik Health Care
The last decade has seen 3D printing innovations redefine what’s possible across a range of industries including automotive, consumer goods, aerospace, and healthcare. However, the adoption of 3D printing technologies for implantable medical devices has been relatively slow. To a large extent, this has been due to challenges in sourcing the right biocompatible materials, the validation of processes, and adhering to quality and regulatory requirements. Where medical device innovation has occurred for 3D printing to date, it has largely been confined to metal-based implants traditionally used for hip, knee, and spine reconstruction applications.